{"id":"https://openalex.org/W2011989818","doi":"https://doi.org/10.1097/00004850-199702001-00005","title":"Sertindole in the treatment of psychosis in schizophrenia: efficacy and safety","display_name":"Sertindole in the treatment of psychosis in schizophrenia: efficacy and safety","alternate_titles":[],"publication_year":1997,"publication_date":"1997-02-01","ids":{"openalex":"https://openalex.org/W2011989818","doi":"https://doi.org/10.1097/00004850-199702001-00005","mag":"2011989818","pmid":"https://pubmed.ncbi.nlm.nih.gov/9179641"},"language":"en","primary_location":{"id":"doi:10.1097/00004850-199702001-00005","doi":"https://doi.org/10.1097/00004850-199702001-00005","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004850-199702001-00005","pdf_url":null,"source":{"id":"https://openalex.org/S149156103","display_name":"International Clinical Psychopharmacology","issn_l":"0268-1315","issn":["0268-1315","1473-5857"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Clinical Psychopharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2011989818"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5023252875","display_name":"Carol A. Tamminga","orcid":"https://orcid.org/0000-0002-6366-5697","observed_orcids":["https://orcid.org/0000-0002-6366-5697"]},"institutions":[{"id":"https://openalex.org/I126744593","display_name":"University of Maryland, Baltimore","ror":"https://ror.org/04rq5mt64","country_code":"US","type":"education","lineage":["https://openalex.org/I126744593"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Carol A. Tamminga","raw_affiliation_strings":["Maryland Psychiatric Research Center, University of Maryland, School of Medicine, Baltimore 21228, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Maryland Psychiatric Research Center, University of Maryland, School of Medicine, Baltimore 21228, USA","institution_ids":["https://openalex.org/I126744593"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000711202","display_name":"Randall J. Mack","orcid":"https://orcid.org/0000-0003-3252-3765","observed_orcids":["https://orcid.org/0000-0003-3252-3765"]},"institutions":[{"id":"https://openalex.org/I126744593","display_name":"University of Maryland, Baltimore","ror":"https://ror.org/04rq5mt64","country_code":"US","type":"education","lineage":["https://openalex.org/I126744593"]},{"id":"https://openalex.org/I4210088555","display_name":"Abbott (United States)","ror":"https://ror.org/0052svj16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088555"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Randall J. Mack","raw_affiliation_strings":["Maryland Psychiatric Research Center, University of Maryland School of Medicine, PO Box 21247, Baltimore, MD 21228, and \u2020Abbott Laboratories, Psychopharmacology Venture, Abbott Park, IL 60064, USA","Abbott Laboratories"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Maryland Psychiatric Research Center, University of Maryland School of Medicine, PO Box 21247, Baltimore, MD 21228, and \u2020Abbott Laboratories, Psychopharmacology Venture, Abbott Park, IL 60064, USA","institution_ids":["https://openalex.org/I126744593"]},{"raw_affiliation_string":"Abbott Laboratories","institution_ids":["https://openalex.org/I4210088555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066149189","display_name":"G. Richard Granneman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I126744593","display_name":"University of Maryland, Baltimore","ror":"https://ror.org/04rq5mt64","country_code":"US","type":"education","lineage":["https://openalex.org/I126744593"]},{"id":"https://openalex.org/I4210088555","display_name":"Abbott (United States)","ror":"https://ror.org/0052svj16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088555"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"G. Richard Granneman","raw_affiliation_strings":["Maryland Psychiatric Research Center, University of Maryland School of Medicine, PO Box 21247, Baltimore, MD 21228, and \u2020Abbott Laboratories, Psychopharmacology Venture, Abbott Park, IL 60064, USA","Abbott Laboratories"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Maryland Psychiatric Research Center, University of Maryland School of Medicine, PO Box 21247, Baltimore, MD 21228, and \u2020Abbott Laboratories, Psychopharmacology Venture, Abbott Park, IL 60064, USA","institution_ids":["https://openalex.org/I126744593"]},{"raw_affiliation_string":"Abbott Laboratories","institution_ids":["https://openalex.org/I4210088555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020647641","display_name":"Christopher Silber","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I126744593","display_name":"University of Maryland, Baltimore","ror":"https://ror.org/04rq5mt64","country_code":"US","type":"education","lineage":["https://openalex.org/I126744593"]},{"id":"https://openalex.org/I4210088555","display_name":"Abbott (United States)","ror":"https://ror.org/0052svj16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088555"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Christopher J. Silber","raw_affiliation_strings":["Maryland Psychiatric Research Center, University of Maryland School of Medicine, PO Box 21247, Baltimore, MD 21228, and \u2020Abbott Laboratories, Psychopharmacology Venture, Abbott Park, IL 60064, USA","Abbott Laboratories"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Maryland Psychiatric Research Center, University of Maryland School of Medicine, PO Box 21247, Baltimore, MD 21228, and \u2020Abbott Laboratories, Psychopharmacology Venture, Abbott Park, IL 60064, USA","institution_ids":["https://openalex.org/I126744593"]},{"raw_affiliation_string":"Abbott Laboratories","institution_ids":["https://openalex.org/I4210088555"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5073891020","display_name":"Kenneth B. Kashkin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I126744593","display_name":"University of Maryland, Baltimore","ror":"https://ror.org/04rq5mt64","country_code":"US","type":"education","lineage":["https://openalex.org/I126744593"]},{"id":"https://openalex.org/I4210088555","display_name":"Abbott (United States)","ror":"https://ror.org/0052svj16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088555"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kenneth B. Kashkin","raw_affiliation_strings":["Maryland Psychiatric Research Center, University of Maryland School of Medicine, PO Box 21247, Baltimore, MD 21228, and \u2020Abbott Laboratories, Psychopharmacology Venture, Abbott Park, IL 60064, USA","Abbott Laboratories"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Maryland Psychiatric Research Center, University of Maryland School of Medicine, PO Box 21247, Baltimore, MD 21228, and \u2020Abbott Laboratories, Psychopharmacology Venture, Abbott Park, IL 60064, USA","institution_ids":["https://openalex.org/I126744593"]},{"raw_affiliation_string":"Abbott Laboratories","institution_ids":["https://openalex.org/I4210088555"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5023252875"],"corresponding_institution_ids":["https://openalex.org/I126744593"],"apc_list":null,"apc_paid":null,"fwci":3.3037,"has_fulltext":false,"cited_by_count":38,"citation_normalized_percentile":{"value":0.91771184,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"12","issue":null,"first_page":"S29","last_page":"S36"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sertindole","display_name":"sertindole","score":1.0},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.9810000061988831},{"id":"https://openalex.org/keywords/psychosis","display_name":"psychosis","score":0.753000020980835},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.8429999947547913},{"id":"https://openalex.org/keywords/positive-symptoms","display_name":"positive symptoms","score":0.7509999871253967},{"id":"https://openalex.org/keywords/negative-symptoms","display_name":"negative symptoms","score":1.0},{"id":"https://openalex.org/keywords/haloperidol","display_name":"haloperidol","score":0.8309999704360962},{"id":"https://openalex.org/keywords/motor-side-effects","display_name":"motor side effects","score":0.9350000023841858},{"id":"https://openalex.org/keywords/clozapine","display_name":"clozapine","score":0.9150000214576721},{"id":"https://openalex.org/keywords/olanzapine","display_name":"olanzapine","score":0.949999988079071},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.7770000100135803}],"concepts":[{"id":"https://openalex.org/C2780777758","wikidata":"https://www.wikidata.org/wiki/Q418050","display_name":"Sertindole","level":4,"score":0.9896454811096191},{"id":"https://openalex.org/C2776619155","wikidata":"https://www.wikidata.org/wiki/Q201872","display_name":"Olanzapine","level":3,"score":0.8888440132141113},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.8203999996185303},{"id":"https://openalex.org/C2780864610","wikidata":"https://www.wikidata.org/wiki/Q221361","display_name":"Clozapine","level":3,"score":0.7893420457839966},{"id":"https://openalex.org/C2780948584","wikidata":"https://www.wikidata.org/wiki/Q251347","display_name":"Haloperidol","level":3,"score":0.7867681384086609},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.6120612621307373},{"id":"https://openalex.org/C2779727114","wikidata":"https://www.wikidata.org/wiki/Q170082","display_name":"Psychosis","level":2,"score":0.5986124277114868},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5190697312355042},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5110737085342407},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4770716428756714},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4275383949279785},{"id":"https://openalex.org/C2776921671","wikidata":"https://www.wikidata.org/wiki/Q758295","display_name":"Atypical antipsychotic","level":4,"score":0.42119863629341125},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.41172194480895996},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.4083205461502075},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.22186726331710815},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.14565107226371765},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1097/00004850-199702001-00005","doi":"https://doi.org/10.1097/00004850-199702001-00005","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004850-199702001-00005","pdf_url":null,"source":{"id":"https://openalex.org/S149156103","display_name":"International Clinical Psychopharmacology","issn_l":"0268-1315","issn":["0268-1315","1473-5857"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Clinical Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:9179641","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9179641","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International clinical psychopharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2402363043","https://openalex.org/W1967717443","https://openalex.org/W2115846160","https://openalex.org/W2774503632","https://openalex.org/W2159529687","https://openalex.org/W2126442695","https://openalex.org/W1974825074","https://openalex.org/W2044336385","https://openalex.org/W2005909500"],"abstract_inverted_index":{"Evidence":[0],"from":[1,43],"clinical":[2],"trials":[3],"supports":[4],"the":[5,31,88,91,105,111],"claim":[6],"that":[7,29,44,51],"sertindole":[8,103],"is":[9,25,40,58,77],"a":[10,15,59,66],"potent":[11,27],"antipsychotic":[12,33,114],"drug":[13,71,108],"at":[14,99],"dose":[16],"of":[17,30,45,52,69],"12-24":[18],"mg/day.":[19],"Its":[20,35,54],"action":[21,36],"against":[22,37,84],"positive":[23],"symptoms":[24,39,86],"as":[26,28],"traditional":[32],"haloperidol.":[34,53],"negative":[38,85,93],"significantly":[41],"different":[42],"placebo":[46],"and":[47,72],"quantitatively":[48],"larger":[49],"than":[50],"most":[55],"distinctive":[56],"characteristic":[57],"reduction":[60],"in":[61],"motor":[62],"side":[63],"effects":[64],"over":[65],"whole":[67],"range":[68],"comparable":[70],"comparator":[73],"doses.":[74],"More":[75],"work":[76],"needed":[78],"to":[79,101],"determine":[80],"whether":[81],"sertindole's":[82],"actions":[83],"influence":[87],"primary":[89],"or":[90,110],"secondary":[92],"system.":[94],"There":[95],"are":[96],"insufficient":[97],"data":[98],"present":[100],"compare":[102],"with":[104],"highly":[106],"efficacious":[107],"clozapine":[109],"other":[112],"new":[113],"olanzapine.":[115]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2011989818","counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
